tiprankstipranks
Passage Bio (PASG)
NASDAQ:PASG
US Market

Passage Bio (PASG) Income Statement

Compare
498 Followers

Passage Bio Income Statement

Last quarter (Q3 2024), Passage Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Passage Bio's net income was $-19.34M. See Passage Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.72M$ -3.68M$ -1.54M$ -800.00K$ -134.00K
Operating Expenses
$ 108.39M$ 135.39M$ 177.73M$ 111.90M$ 36.69M
Depreciation and Amortization
$ 3.72M$ 3.68M$ 1.54M$ 800.00K$ 134.00K
EBITDA
$ -98.34M$ -138.39M$ -185.73M$ -112.90M$ -36.55M
Operating Income
$ -108.39M$ -138.39M$ -185.73M$ -112.90M$ -37.19M
Other Income/Expenses
$ 6.33M$ 2.27M$ 343.00K$ 670.00K$ -8.45M
Pretax Income
$ -102.06M$ -136.13M$ -185.39M$ -112.23M$ -45.63M
Net Income
$ -102.06M$ -136.86M$ -191.50M$ -111.76M$ -54.58M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.86$ -2.51$ -3.59$ -2.89$ -1.19
Diluted EPS
$ -1.86$ -2.51$ -3.59$ -2.89$ -1.19
Weighted Average Shares Outstanding
54.74M 54.43M 53.34M 38.62M 45.80M
Weighted Average Shares Outstanding (Diluted)
54.74M 54.43M 53.34M 38.62M 45.80M
Currency in USD

Passage Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis